Literature DB >> 9610669

Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action.

R D Mellon1, B M Bayer.   

Abstract

This review will discuss studies demonstrating that activation of opioid receptors within the central nervous system alters various immune system parameters. Specifically, natural killer cell cytolytic activity and lymphocyte proliferative responses to mitogen appear to be modulated predominantly, if not exclusively, through central opioid receptors. The potential mechanisms by which central opioid receptors appear to modulate these peripheral immune functions will be examined by evaluating the role of both the hypothalamic-pituitary-adrenal (HPA) axis and the autonomic nervous system. The studies discussed below indicate that acute administration of morphine or related compounds appears to primarily alter peripheral immune function through the sympathetic nervous system, while more prolonged exposure to opioids alter the immune system predominantly by activation of the HPA axis. Finally, the potential clinical relevance of these observations are discussed in relationship to both the therapeutic use, as well as the abuse of opioid compounds.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9610669     DOI: 10.1016/s0165-5728(97)00217-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  37 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 2.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

Review 3.  Effects of opioid tolerance and withdrawal on the immune system.

Authors:  Toby K Eisenstein; Rahil T Rahim; Pu Feng; Nita K Thingalaya; Joseph J Meissler
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-23       Impact factor: 4.147

Review 4.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

Review 5.  Anesthetics, immune cells, and immune responses.

Authors:  Shin Kurosawa; Masato Kato
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

6.  Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity.

Authors:  Parvathi Ranganathan; Hao Chen; Miranda K Adelman; Samuel F Schluter
Journal:  J Neuroimmunol       Date:  2009-10-30       Impact factor: 3.478

Review 7.  [Influence of anesthesia procedure on malignant tumor outcome].

Authors:  K Fukui; C Werner; G Pestel
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

Review 8.  Intensive Care Unit-acquired infection as a side effect of sedation.

Authors:  Saad Nseir; Demosthenes Makris; Daniel Mathieu; Alain Durocher; Charles-Hugo Marquette
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

Review 9.  Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system.

Authors:  Thomas J Connor
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

10.  Morphine-induced enhancement in the granulocyte response to thioglycollate administration in the rat.

Authors:  Karamarie Fecho; Donald T Lysle
Journal:  Inflammation       Date:  2002-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.